Latest filing published 22 Sept 2026 for GSK plc, €445.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Hal Dietz: trading record in brief
All filings by Hal Dietz on record concern GSK plc. Between 23 September 2022 and 18 September 2026, the trades on record add up to 3 filings.
Purchases make up the whole of the open-market record (1 purchase, €33k). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 2 share grants. 2026 to date brings 1 purchase and no sales.
The newest entry dates from 22 September 2026: an open-market purchase of €33k, in GSK plc. The median gap between a trade and its publication by RNS (LSE) is 3 days. The legal deadline for notifying a trade is three business days (UK MAR). Every figure here comes from the filings published by RNS (LSE) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Hal Dietz
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 768 shares@ £0.4985New York Stock Exchange (XNYS)ISIN US37733W2044FCA-NSM:6d07555a-8fe0-4cf5-bc3a-79471d424d47-4Canonical exit: 17 Dec 2026 (T+90)
1 of 1 declaration
